Climb Bio Inc <CLYM.O>: RBC initiates coverage with Outperform rating; target price $23
CLYM•Related News
Luckin Coffee Q2 FY26 net income climbs 16.1% to RMB 1.49 billion; total net revenues rise 28.5% to RMB 15.89 billion
LKNCY•
InMode holds annual shareholder meeting
INMD•
Marriott raises annual room revenue growth forecast
MAR•
PBF Energy Inc <PBF.N>: JP Morgan Raises Target Price to $83 From $57
PBF•
Precision BioSciences CFO Naresh Tanna files initial beneficial ownership statement
DTIL•